Europe Telemedicine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Europe Telemedicine Market is Segmented by Type (Telehospitals, Telehomes, and mHealth), By Component (By Product & Services), Mode of Delivery (On-premise Delivery and Cloud-based Delivery), and Country (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe). The report offers the value (in USD million) for the above segments.

Market Snapshot

Europe Telemedicine Market Bar Graph
Study Period: 2018-2026
Base Year: 2020
CAGR: 18.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Europe telemedicine market was valued at USD 10,619 million in 2020, and it is expected to reach USD 29,975 million in 2026, registering a CAGR of 18.8% during the forecast period, 2021-2026.

Telemedicine or telehealth has emerged as an essential component of healthcare during the current COVID-19 crisis. The countries not only in Europe but globally have accelerated the adoption of digital health. As per the study published by the Paris Region Institute in April 2020, France has seen a major surge in teleconsultation from 10,000 teleconsultations per week before confinement to more than a million the last week of April, a multiplication by 100. This is the major factor propelling the growth of the market.

Also, rising healthcare expenditure, increasing preference for remote patient monitoring, and the rising burden of chronic diseases are the factors propelling the growth in this region. For instance, in 2018, according to the GLOBOCAN report, cancer affected more than 12 million people in Europe. To leverage the potential opportunities, the players in the market are coming up with technological innovations and product launches as the growth driver for their company and the market in this region. For instance, in August 2020, a new digital health company, named HealthHero, was launched in the focused European market.

However, several legal and reimbursement issues, requirement of high initial capital, and lack of physician support are expected to be the major restraints for the market growth.​

Scope of the Report

As per the scope of the report, telemedicine refers to the remote diagnosis and treatment of patients with the help of telecommunication technology. Further, various kinds of telemedicine services, along with devices, have been tracked. The telemedicine services include telepathology, telecardiology, teleradiology, teledermatology, telepsychiatry, etc. The Europe telemedicine market is segmented by type (telehospitals, telehomes, and mHealth), by Component (product & services), mode of delivery (on-premise delivery and cloud-based delivery), and country (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Type
mHealth (Mobile Health)
By Component
By Product
Other Products
By Services
Other Clinical Services
By Mode of Delivery
On-premise Delivery
Cloud-based Delivery
By Country
United Kingdom
Rest of Europe

Report scope can be customized per your requirements. Click here.

Key Market Trends

The mHealth Segment is Expected to be the Fastest Growing Segment over the Forecast Period

MHealth has emerged as the most important asset to keep track of health during the COVID-19 crisis. The region has seen an upsurge in the usage of mobile health applications during the crisis. Various regulatory bodies in Europe are also promoting the use of mHealth applications. In December 2020, the National Institute for Health and Disability Insurance (INAMI-RIZIV), Europe, launched a pilot project concerning the remote monitoring of COVID-19 patients before and after their hospitalization as part of an integrated medical approach supported by digital applications. Overall, the COVID-19 crisis has a positive impact on the growth of the market.

Also, the rise of chronic diseases is a major concern that puts a strain on healthcare resources. MHealth is an innovative way to provide care, monitor a patient, and provide information using the latest technology. Monitoring allows the early identification of diseases, preventing chronic conditions. The potential advantages have led to the increasing adoption of mHealth technologies, and players in this region are coming up with innovative launches to further increase the adaptability in this region. For instance, in early January 2021, the Rehappy health app was launched by the directory of digital health applications for stroke patients in Germany. Thus, the increasing development by the players, coupled with rising initiatives by the government for mHealth, are expected to propel the growth of this segment.

Europe Telemedicine Market Key Trends

Competitive Landscape

The market comprises few major market players, and these players are focusing on technological advancements, strategic partnerships, and mergers to acquire the major market share. For instance, in April 2019, Boston Scientific signed a strategic partnership with Wellframe to deliver digital heart health management solutions and personalized education to patients. The market has been noticing technological developments on a large scale for the past couple of years. Integration of services, such as EMR, picture archiving and communication systems (PACS), telehealth services, RFID, etc., has been gaining increasing importance in Europe.

Recent Developments

  • In March 2020, Kry, a Swedish telehealth start-up, launched the platform Care Connect by Kry, a tool for healthcare professionals to conduct remote consultations during the coronavirus pandemic in the European market.
  • In February 2020, CompuGroup Medical, a German healthcare software company, acquired Cerner healthcare IT assets, including medico and Soarian Integrated Care, which are health information systems in Germany and Spain, for USD 248 million. This deal is expected to strengthen CompuGroup's position in the market space.

Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Healthcare Costs

      2. 4.2.2 Technological Innovations

      3. 4.2.3 Increasing Remote Patient Monitoring

      4. 4.2.4 Growing Burden of Chronic Diseases

    3. 4.3 Market Restraints

      1. 4.3.1 Legal and Reimbursement Issues

      2. 4.3.2 High Initial Capital Requirements and Lack of Physician Support

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Type

      1. 5.1.1 Telehospitals

      2. 5.1.2 Telehomes

      3. 5.1.3 mHealth (Mobile Health)

    2. 5.2 By Component

      1. 5.2.1 By Product

        1. Hardware

        2. Software

        3. Other Products

      2. 5.2.2 By Services

        1. Telepathology

        2. Telecardiology

        3. Teleradiology

        4. Teledermatology

        5. Telepsychiatry

        6. Other Clinical Services

    3. 5.3 By Mode of Delivery

      1. 5.3.1 On-premise Delivery

      2. 5.3.2 Cloud-based Delivery

    4. 5.4 By Country

      1. 5.4.1 Germany

      2. 5.4.2 United Kingdom

      3. 5.4.3 France

      4. 5.4.4 Italy

      5. 5.4.5 Spain

      6. 5.4.6 Rest of Europe


    1. 6.1 Company Profiles

      1. 6.1.1 Aerotel Medical Systems (1998) Ltd

      2. 6.1.2 Allscripts Healthcare Solutions Inc.

      3. 6.1.3 AMD Global Telemedicine Inc.

      4. 6.1.4 OTH.IO

      5. 6.1.5 International business Machinery Corporation (IBM)

      6. 6.1.6 Teladoc Health Inc. (InTouch Technologies Inc.)

      7. 6.1.7 Resideo Technologies Inc. (Honeywell Life Care Solutions)

      8. 6.1.8 Koninklijke Philips NV

      9. 6.1.9 Medtronic PLC

      10. 6.1.10 SHL Telemedicine

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Europe Telemedicine Market market is studied from 2018 - 2026.

The Europe Telemedicine Market is growing at a CAGR of 18.8% over the next 5 years.

The Europe Telemedicine Market is valued at 10619 Million USD in 2018.

The Europe Telemedicine Market is valued at 29975 Million USD in 2026.

IBM Corporation, Allscripts Healthcare Solutions Inc., BioTelemetry Inc., Koninklijke Philips NV, Medtronic Plc are the major companies operating in Europe Telemedicine Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!